ARCHIVES

Tivozanib Does Not Improve OS Compared to Sorafenib

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: AACR To Have Fur Symposia, Including One With ASCO; McConnell Names TRTP Director

March 21, 1986

Nexavar Approved For Patients With Inoperable Liver Cancer

November 30, 2007

Two-Drug Combination Extends Survival Of Mesothelioma

May 31, 2002

DCT Board Delays Action On Protein Index, Refuses Support for Cow Study, Approves Various Concepts

October 16, 1981

DCT Board Okays Concepts For New Radiation Studies

June 12, 1987

SAIC Begins Transition Of Frederick Operations From Incumbent PRI

March 17, 1995